FOCUS MEETS UK CONCLUSION
And FOCUS 2024 announcement
PROSTATE CANCER with the support of ADACAP
Metabolic imaging in GU cancers Future association between local and vectorized treatment in PCa Internal vectorized radiotherapy sequences in the management of metastatic prostate cancer
PROSTATE CANCER
Micro ultrasound versus MRI fusion biopsies Active surveillance without biopsy: ready for prime time? YES versus NO
PROSTATE CANCER with the support of Astellas
New challenges and opportunities in the management of genito-urinary cancers Treatment sequencing in the management of metastatic urothelial cancers Management of high-risk biochemical relapse after... Read More
KIDNEY CANCER with the support of Ipsen
Specific clinical settings in the era of new treatments Management of metastatic non-clear cell kidney cancer Delayed nephrectomies: potential indications and outcomes
PROSTATE CANCER with the support of Bayer
Which second generation hormonal treatment to choose in mHSPC? A personalized approach Metachronous low volume mHSPC: intermitent, doublet or triplet therapy? Strategy to delay systemic... Read More
European Corner, CC-AFU/YAU-EAU Joint session – France UK
Implementation of biomarkers in daily practice How to use biomarkers from localized to castration resistant prostate cancer? How to use biomarkers from NMIBC to metastatic... Read More